Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Greenwich Lifesciences Inc
(NQ:
GLSI
)
14.88
+0.74 (+5.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Greenwich Lifesciences Inc
< Previous
1
2
3
Next >
3 Stocks Insiders Are Buying on Market Turbulence
January 27, 2022
When insiders buy a stock, you should take it as a sign that they think good news is about to come out. Here are three to watch closely.
Via
InvestorPlace
65 Biggest Movers From Yesterday
January 25, 2022
Gainers Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated...
Via
Benzinga
Greenwich LifeSciences to Implement Stock Repurchase Program for up to $10 Million & to Extend Lock-up of Insiders for an Additional 1 Year
January 24, 2022
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences CEO Participates in TD Ameritrade Interview to Discuss 2021 SABCS Poster
December 15, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Reveals 5-Year Data for GP2 Immunotherapy In Breast Cancer Settings
December 09, 2021
Greenwich LifeSciences Inc (NASDAQ: GLSI) has published new GP2 Phase 2b trial data. The trial enrolled HER2 positive patients, who received a standard course of...
Via
Benzinga
Greenwich LifeSciences Announces Presentation of 5 Year Data for GP2 Phase IIb Clinical Trial, Revealing Potential For New T Cell Platform Technology
December 09, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences to Participate in Multiple Interviews and Conferences
December 08, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Expands Role of Industry Expert Dr. F. Joseph Daugherty to Include Medical Monitor for its Upcoming Phase III Clinical Trial
December 07, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Announces Commencement of the First Commercial Line Filling of GP2
December 06, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences CEO Interview to Air on Bloomberg U.S. on the RedChip Money Report
November 18, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
58 Biggest Movers From Friday
December 06, 2021
Gainers Hagerty, Inc. (NYSE: HGTY) shares jumped 46.5% to close at $15.62. TuanChe Limited (NASDAQ: TC) gained 44.7% to settle at $3.30. IO Biotech, Inc. (NASDAQ: IOBT) shares...
Via
Benzinga
Greenwich LifeSciences to Participate in Jefferies’ 12th Annual London Healthcare Conference
November 17, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Announces Acceptance of Two Posters at Upcoming 2021 SABCS Breast Cancer Conference
November 11, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Provides Clinical Update on Upcoming Phase III Clinical Trial, FLAMINGO-01
November 10, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Provides Updated Corporate Presentation and Webcasts
November 09, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
The Moonshot Investor: The Insider Track Strategy
October 08, 2021
Excerpts of this article were originally published on October 4 and 18, 2021, as part of Tom Yeung's Moonshot Investor series. Investors interested in
Via
InvestorPlace
3 Stocks Insiders Are Snapping Up. Do They Know Something We Don’t?
October 05, 2021
Insider trading is heavily regulated, but it still happens, and it's worth paying attention to big moves from insiders for potential profits.
Via
InvestorPlace
Greenwich LifeSciences to Partner with Susan G. Komen Race for the Cure Houston
September 28, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences to Present at the Benzinga Healthcare Small Cap Conference
September 27, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences to Present at the Cantor Global Healthcare Conference
September 23, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 13, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Provides Updates on Recent and Upcoming Developments
September 09, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences to Participate in Citi’s 16th Annual Biopharma Virtual Conference
September 07, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Set to Join Russell 2000® Index
June 08, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021
September 01, 2021
Upgrades For Chatham Lodging Trust (NYSE:
Via
Benzinga
Greenwich LifeSciences' Breast Cancer Vaccine Unveils Five Year Data, Confirming to Prevent Metastatic Breast Cancer Recurrence
June 07, 2021
Greenwich LifeSciences Inc (NASDAQ: GLSI) presented five-year data from Phase 2 breast cancer clinical trial evaluating GP2 immunotherapy in patients who have...
Via
Benzinga
Greenwich LifeSciences Publishes Additional Positive Safety Data from GP2 Phase IIb Trial at ASCO 2021, Confirming that GP2 Treatment to Prevent Metastatic Breast Cancer Recurrence is Well Tolerated
June 07, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 02, 2021
Gainers Tilray (NASDAQ:TLRY) shares incre...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 22, 2021
Gainers Renalytix AI (NASDAQ:RNLX) shares rose 21.41% to $30.62 during Thursday's regular session. Renalytix AI's stock is trading at a volume of 1.0 million...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
1 Drug, 1 Mission: What Should Investors Expect for Greenwich Life Sciences?
April 21, 2021
The top-performing IPO of 2020 is a high-risk, high-reward opportunity, with one drug in its pipeline and one disease in its sights. Is it worth investing in now?
Via
The Motley Fool
Topics
Initial Public Offering
Exposures
Securities Market
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.